Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 6/20 | 0.59 |
| ▸ | TAS1R1 | Q7RTX1 | 6/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL445605 | 0.93 | TAS1R3 (0.64) | TAS1R3TAS1R1ALDH1A1NPC1RAB9A | |
| SCHEMBL4257549 | 0.84 | PIN1 (0.43) | TAS1R3TAS1R1NPC1RAB9ASMPD1 | |
| SCHEMBL4254240 | 0.84 | SMPD1 (0.40) | TAS1R3TAS1R1ALDH1A1NPC1RAB9A | |
| SCHEMBL4251053 | 0.82 | TAS1R3 (0.62) | TAS1R3TAS1R1ALDH1A1NPC1RAB9A | |
| SCHEMBL4254244 | 0.80 | SMN1; SMN2 (0.60) | ALDH1A1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL4251260 | 0.79 | HPGD (0.56) | ALDH1A1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL4247914 | 0.78 | ALDH1A1 (0.45) | TAS1R3TAS1R1ALDH1A1NPC1RAB9A | |
| SCHEMBL445824 | 0.77 | TAS1R3 (0.66) | TAS1R3TAS1R1ALDH1A1NPC1RAB9A | |
| SCHEMBL4199720 | 0.76 | TAS1R3 (1.00) | TAS1R3TAS1R1ALDH1A1NPC1RAB9A | |
| SCHEMBL443684 | 0.76 | SMPD1 (0.48) | TAS1R3TAS1R1NPC1RAB9ASMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023798-A1 | THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | PHARMACYCLICS, INC. (US) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023798-A1 | THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC8, HDAC3 | TAS1R3 3722/4885TAS1R1 3753/4885ALDH1A1 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.